19 results
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
7 May 24
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
4:05pm
and sex hormone binding globulin (SHBG), an indicator of target engagement in the liver
The Phase 2a HERALD study was initiated in Q1 2024
DEF 14A
p628xbe5tp3ovp
27 Apr 21
Definitive proxy
4:15pm
8-K
EX-3.2
r6j8bc
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:03pm
PRE 14A
t9h70ua
16 Apr 24
Preliminary proxy
5:27pm
8-K
EX-10.1
iu0qs0wtd6d p4lrq
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
S-1
EX-10.3
h6n4h68pqv7 rm1
25 Sep 20
IPO registration
5:27pm
S-1
mnbfz ms4
25 Sep 20
IPO registration
5:27pm
DRS
kxghtgydm7v1r9t41a
26 Aug 20
Draft registration statement
12:00am
424B4
4zhqb0cbbhafhjp
19 Oct 20
Prospectus supplement with pricing info
5:21pm
- Prev
- 1
- Next